Stockreport

Lisata Therapeutics to Participate in Upcoming September 2024 Industry and Investor Events

Lisata Therapeutics, Inc.  (LSTA) 
PDF BASKING RIDGE, N.J. , Sept. 09, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company [Read more]